RééDOC
75 Boulevard Lobau
54042 NANCY cedex

Christelle Grandidier Documentaliste
03 83 52 67 64


F Nous contacter

0

Article

--";3! O

-A +A

Metabolic syndrome across Europe : different clusters of risk factors

SCUTERI A; LAURENT S; CUCCA F; COCKCROFT J; CUNHA PG; MANAS LR; RASO FU; MUIESAN ML; RYLISKYTE L; RIETZSCHEL E; STRAIT J; VLACHOPOULOS C; VOLZKE H; LAKATTA EG; NILSSON PM
EUR J PREV CARDIOL , 2015, vol. 22, n° 4, p. 486-491
Doc n°: 173297
Localisation : Rééducation CHU Brabois Adultes

D.O.I. : http://dx.doi.org/DOI:10.1177/2047487314525529
Descripteurs : GA - DIABETE

Metabolic syndrome (MetS) remains a controversial entity. Specific
clusters of MetS components - rather than MetS per se - are associated with
accelerated arterial ageing and with cardiovascular (CV) events. To investigate
whether the distribution of clusters of MetS components differed
cross-culturally, we studied 34,821 subjects from 12 cohorts from 10 European
countries and one cohort from the USA in the MARE (Metabolic syndrome and
Arteries REsearch) Consortium. METHODS: In accordance with the ATP III criteria,
MetS was defined as an alteration three or more of the following five components:
elevated glucose (G), fasting glucose >/=110 mg/dl; low HDL cholesterol, <
40mg/dl for men or <50 mg/dl for women; high triglycerides (T), >/=150 mg/dl;
elevated blood pressure (B), >/=130/>/=85 mmHg; abdominal obesity (W), waist
circumference >102 cm for men or >88 cm for women. RESULTS: MetS had a 24.3%
prevalence (8468 subjects: 23.9% in men vs. 24.6% in women, p < 0.001) with an
age-associated increase in its prevalence in all the cohorts. The age-adjusted
prevalence of the clusters of MetS components previously associated with greater
arterial and CV burden differed across countries (p < 0.0001) and in men and
women (p < 0.0001). In details, the cluster TBW was observed in 12% of the
subjects with MetS, but was far more common in the cohorts from the UK (32.3%),
Sardinia in Italy (19.6%), and Germany (18.5%) and less prevalent in the cohorts
from Sweden (1.2%), Spain (2.6%), and the USA (2.5%). The cluster GBW accounted
for 12.7% of subjects with MetS with higher occurrence in Southern Europe (Italy,
Spain, and Portugal: 31.4, 18.4, and 17.1% respectively) and in Belgium (20.4%),
than in Northern Europe (Germany, Sweden, and Lithuania: 7.6, 9.4, and 9.6%
respectively). CONCLUSIONS: The analysis of the distribution of MetS suggested
that what follows under the common definition of MetS is not a unique entity
rather a constellation of cluster of MetS components, likely selectively risky
for CV disease, whose occurrence differs across countries.
CI - (c) The European Society of Cardiology 2014 Reprints and permissions:
sagepub.co.uk/journalsPermissions.nav.

Langue : ANGLAIS

Mes paniers

4

Gerer mes paniers

0